Clinical Research

Found 101,386 articles

• Q BioMed Announces Identification and Production of New Proprietary Drug Candidate for Pediatric Nonverbal Disorder

  10/19/2017

  Q BioMed today that it has successfully developed a new and proprietary analog of QBM-001 in partnership with Sphaera Pharma for its intended use in pediatric developmental nonverbal disorder.

• Zogenix: High Seizure Frequency in Children With Dravet Syndrome Negatively Impacts Quality of Life, New International Caregiver Survey Finds

  10/19/2017

  The results suggest a need for more effective antiepileptic treatments.

• CytoSorbents Release: CytoSorb Usage During Valve Replacement Surgery for Infective Endocarditis Helps Stabilize Patients and May Improve Survival

  10/19/2017

  CytoSorbents highlights the largest endocarditis valve replacement study using CytoSorb published to date entitled, "Hemoadsorption treatment of patients with acute infective endocarditis during surgery with cardiopulmonary bypass - a case series".

• Myriad's GeneSight Shown to Statistically Significantly Improve Generalized Anxiety Disorder Treatment Response and Decrease Benzodiazepine Use

  10/19/2017

  The positive results were presented at the 25th World Congress of Psychiatric Genetics.

• Pixium Vision Receives Approval For First-In-Human Clinical Trial Of PRIMA, Its Miniaturized Sub-Retinal Implant

  10/19/2017

  Pixium Vision announces that its next-generation miniaturized wireless sub-retinal implant, PRIMA, received authorization from the French regulatory agency, to start a feasibility clinical study in patients with advanced dry age-related macular degeneration (dry-AMD).

• Novartis Drug Revolade Shows Long-Term Disease Control for Chronic/Persistent Immune Thrombocytopenia (ITP)

  10/18/2017

  The long term study results were published online in Blood.

• Novartis Drug Promacta Shows Long-Term Disease Control For Chronic/Persistent Immune Thrombocytopenia

  10/18/2017

  Novartis today announced long-term study results supporting the positive safety and efficacy of Promacta (eltrombopag) in adults with chronic/persistent immune (idiopathic) thrombocytopenia (ITP).

• SCORR Marketing And Applied Clinical Trials Release Report On Collaborative R&D In The Drug Development Industry

  10/18/2017

  SCORR Marketing, a global health science marketing and communications firm, and Applied Clinical Trials have released a new study, Collaborative R&D Survey Report.

• Virginia Tech Release: Successful Treatment Of Canine Brain Tumor Offers Hope To Humans

  10/18/2017

  "Q" Bentley, a canine patient of Bush Veterinary Neurology Service (BVNS), has had a remarkable response to treatment of a glioma brain tumor. The treatment was performed through a clinical trial at the Virginia-Maryland College of Veterinary Medicine at Virginia Tech, funded by the National Institutes of Health.

• PharmaCyte Biotech Research Identifies Enzyme Activity for Cannabinoid-Based Therapy to Fight Cancer

  10/18/2017

  PharmaCyte Biotech announced that its research partner, the University of Northern Colorado, has identified an organism whose genome contains the genetic code for production of an enzyme capable of activating a cannabinoid prodrug into its active cancer-killing form.

• Synergy Pharmaceuticals Presents Results From Study Examining Patient And Physician Perceptions And Experiences With Irritable Bowel Syndrome With Constipation (IBS-C)

  10/18/2017

  Synergy Pharma announced today new findings highlighting the frustration of patients suffering from irritable bowel syndrome with constipation (IBS-C) and the perceptions of healthcare providers (HCPs) who treat these patients.

• Conceivex Release: Nation's Leading Fertility Therapy Company Appoints Life Sciences Veteran To Board of Directors

  10/18/2017

  Conceivex, maker of The Conception Kit at-home system, today named veteran life sciences industry executive Michael S. Rosen to its Board of Directors.

• Trovagene's PLK1 Inhibitor (PCM-075) Demonstrates Synergy with Zytiga® (abiraterone acetate) in Castration Resistant Prostate Cancer Tumor Cells

  10/18/2017

  Trovagene today announced positive data from preclinical research demonstrating synergy of PCM-075, its oral, highly-selective Polo-like Kinase 1 (PLK1) Inhibitor, in combination with abiraterone (Zytiga - J&J)/

• Anatomics Release: American Surgical Team Successfully Completes First 3D Printed Titanium and Polymer Sternum Implant Procedure in the United States

  10/18/2017

  On August 2, 2017, an American surgical team conducted a surgery to replace the sternum and partial ribcage of a 20 year-old woman using a custom 3D-printed composite titanium/porous polyethylene implant. It is the first time this technology has been used in the United States and only the second time in the world that a 3D-printed composite sternum and ribcage has been implanted.

• Androvia LifeSciences Announces Results from a Health Economics and Outcomes Research Study Highlighting the Potential Cost Impact of the Cap-Score Sperm Function Test

  10/18/2017

  The Cap-Score is projected to improve pregnancy rates and save couples time and money.

• NRGene Technology Efficiently Analyzes Abnormalities in Multiple Human Genomes

  10/18/2017

  NRGene has demonstrated its ability to discover, analyze, and track abnormalities within the human genome, across multiple subjects.

• HistoGeneX: BluePrint Phase II Demonstrates Digital Pathology Review Equivalent to Glass Slides

  10/18/2017

  In this landmark study, a follow-up to BluePrint 1, a global team of thoracic pathologists reviewed the immunostains of five clinical grade PD-L1 IHC assays (22C3, 28-8, SP142, SP263, and 73-10).

• Anpac Bio Surpasses 50,000 Case Study Milestone 'Liquid Biopsy Pioneer' Serving Individual, Medical, Insurance & Corporate Customers

  10/18/2017

  Dr. Chris Yu, CEO of international life sciences corporation Anpac Bio-Medical Science Company, announced this week the company set a new, international record, processing and reporting over 50,000 cases worldwide of the company's proprietary, "Cancer Differentiation Analysis" (CDA) liquid biopsy tests.

• Interpace Diagnostics Presents New Data from Over 3,400 Patients Tested with ThyGenX/ThyraMIR

  10/18/2017

  Conclusions will be presented at the American Thyroid Association annual meeting.

• Hemoglobin Oxygen Therapeutics LLC Announces the World's First Human Liver Transplantation After Ex-Situ Normothermic Machine Perfusion Using Hemopure®

  10/18/2017

  HBO2 Therapeutics is the leading developer of hemoglobin based solutions that increase the oxygen carrying capacity of blood.